Skip to content

Clinical trials

Terminated Cholangiocarcinoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Status: Terminated Country / region: France Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20091
20111
20161
20171
20181
20196
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
Assistance Publique - Hôpitaux de Paris1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
Genoscience Pharma1
Helsinn Healthcare SA1
IHU Strasbourg1
Incyte Corporation1
NuCana plc1
PCI Biotech AS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma15
Biliary Tract Neoplasms3
Bile Duct Neoplasms2
Gallbladder Neoplasms2
Sarcoma2
Adenocarcinoma1
Adenocarcinoma of Lung1
Breast Neoplasms1
Camurati-Engelmann Syndrome1
Carcinoma1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.